1. Home
  2. PAHC vs EOS Comparison

PAHC vs EOS Comparison

Compare PAHC & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$31.02

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Enhance Equity Income Fund II

EOS

Eaton Vance Enhance Equity Income Fund II

HOLD

Current Price

$21.91

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAHC
EOS
Founded
1946
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
PAHC
EOS
Price
$31.02
$21.91
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$41.25
N/A
AVG Volume (30 Days)
315.5K
130.0K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
0.91%
N/A
EPS Growth
1883.33
N/A
EPS
1.90
N/A
Revenue
$833,350,000.00
N/A
Revenue This Year
$17.03
N/A
Revenue Next Year
$3.82
N/A
P/E Ratio
$16.77
N/A
Revenue Growth
4.12
N/A
52 Week Low
$23.57
$19.44
52 Week High
$60.08
$24.49

Technical Indicators

Market Signals
Indicator
PAHC
EOS
Relative Strength Index (RSI) 35.29 39.53
Support Level $28.25 $21.73
Resistance Level $34.49 $22.99
Average True Range (ATR) 1.50 0.35
MACD 0.73 -0.10
Stochastic Oscillator 45.30 11.90

Price Performance

Historical Comparison
PAHC
EOS

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About EOS Eaton Vance Enhance Equity Income Fund II

Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.

Share on Social Networks: